Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro Sort descending
  • Site
  • Posizione
  • Divisione
  • Business
  • Area funzionale
  • Data di pubblicazione
Titolo di lavoro Sort descending Site Posizione Divisione Business Area funzionale Data di pubblicazione
Territory Business Executive Uttar Pradesh India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Uttar Pradesh India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Madhya Pradesh India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Madhya Pradesh India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Chattisgarh India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Tamil Nadu India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Kerala India International Innovative Medicines I saldi Ott 01, 2024
TERRITORY BUSINESS EXECUTIVE Delhi Territory India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Karnataka India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Jammu & Kashmir India International Innovative Medicines I saldi Ott 01, 2024
TERRITORY BUSINESS EXECUTIVE Rajasthan India International Innovative Medicines I saldi Ott 01, 2024
Territory Business Executive Telangana India International Innovative Medicines I saldi Ott 14, 2024
Territory Business Executive Chandigarh (Territory) India International Innovative Medicines I saldi Ott 14, 2024
TERRITORY BUSINESS EXECUTIVE-1 Rajasthan India International Innovative Medicines I saldi Ott 01, 2024
Territory Sales Manager Cardio: Prague Prague Repubblica Ceca International Innovative Medicines I saldi Ott 14, 2024
Territory Sales Manager Immunology: Moravia Prague Repubblica Ceca International Innovative Medicines I saldi Ott 11, 2024
Therapeutic Area Biomarker Lead Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Mag 28, 2024
Therapeutic Area Head Hematology (region LACan) East Hanover USA International Innovative Medicines Gestione commerciale e generale Ott 14, 2024
Therapeutic Area Head PKS (Global Health) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Set 03, 2024
Therapeutic Area Partner - Kuwait Kuwait Kuwait International Innovative Medicines I saldi Apr 23, 2024
Therapeutic Data Strategy Director East Hanover USA Development Innovative Medicines Research & Development Lug 02, 2024
Therapy Area Lead (ONCO/Hema & NS/Imm) Kyiv Ucraina International Innovative Medicines Gestione commerciale e generale Apr 16, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Therapy Area Partner Abha Arabia Saudita International Innovative Medicines I saldi Ott 01, 2024
Third Party Risk Management Specialist Prague Repubblica Ceca Operations CTS procurement Lug 30, 2024
Time Service Delivery Expert - CZ, SK & HU Prague Repubblica Ceca People & Organization CTS Risorse umane Ott 02, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Giappone Biomedical Research Pharma Research Research & Development Lug 07, 2024
Trainee Marketing (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germania International Innovative Medicines Marketing Ott 18, 2024
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit e finanza Ago 12, 2024
Treasury Cash Management Payment Specialist INSURGENTES Messico Finance CTS Audit e finanza Ott 16, 2024
Treasury Manager Moscow (City) Fed. Russa Finance CTS Audit e finanza Giu 20, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Set 03, 2024
Trial Vendor Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Set 03, 2024
US Market Access Future Leaders Program East Hanover USA US Innovative Medicines Market Access Ott 18, 2024
Utilities Maintenance & Reliability Engineer - Site Amiria Egitto Operations Innovative Medicines Technical Operations Ago 19, 2024
UX/UI Designer Prague Repubblica Ceca Operations CTS Technology Transformation Ott 10, 2024
Validation Expert İstanbul Kurtköy Turchia Operations Innovative Medicines Technical Operations Set 03, 2024
Validation Expert İstanbul Kurtköy Turchia Operations Innovative Medicines Technical Operations Lug 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia